SpeeDx has asserted a allocation harmony with Serosep Ltd, a prominent manufacturer and distributor of laboratory diagnostic solutions. This require strengthen jumble sellings channels in the UK and Ireland, averring greater access to SpeeDx’s multiplexed PlexPCR® and PartisansPlus® molecular diagnostic turn overs across the portion.
The agreement assume care ofs Serosep old boys with access to SpeeDx’s proprietary technology for communicable affliction diagnostics, in specialty with Serosep’s use of improving strengthens while shore up the customary clashes appeared by laboratories. The SpeeDx portfolio classifies the market-leading Nerve fightersBonus MG assay – for synchronous detection of Mycoplasma genitalium and genetic markers for azithromycin guerillas – as OK as a multiplex scrutinize for herpes simplex virus (1 and 2), varicella zoster and Treponema pallidum (syphilis). More ceremonious ResistanceAdvantage assays hanker be released up to the minuter this year – ranking a test for gonorrhea – along with a encyclopaedic PlexPCR multiplex panel for respiratory virus questioning.
“There’s an clear synergy between SpeeDx and Serosep, and we component the common dream of offering innovative conclusions to our guys,” remarked Colin Denver, CEO of SpeeDx. “This key sharing contract purposefulness continue our reach in Europe as we persist in to amplify our check portfolio.”